Buspirone in ADHD
Not Applicable
- Conditions
- Attention Deficit Hyperactivity Disorder.Disturbance of activity and attention
- Registration Number
- IRCT201104116168N1
- Lead Sponsor
- euroscience Research Center Kerman University of Medical Sciences, Kerman ,Iran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
ADHD diagnosis according to DSM-IV-TR criteria that scored above 20 in ADHD-Rating Scale. Exclusion criteria: evidence of a mental retardation(IQ<70) or a major psychiatric problem other than oppositional defiant disorder and conduct disorder or receiving any psychotropic medication through 2 weeks before initiating treatment; medical disorders that would preclude the safe use of methylphenidate or buspirone.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hyperactivity, impulsivity and inattention symptoms according to parent and teacher point of view. Timepoint: every 2 weeks. Method of measurement: ADHD Rating Scale(parent and teacher form).
- Secondary Outcome Measures
Name Time Method Side effects include increase or decrease of appetite,weight and sleep,tic,stomachach. Timepoint: every 2 weeks. Method of measurement: Checklist of each drug side effects.